Blood markers for poor outcomes after sepsis in cancer surgery
Treatments studied
Part of Infections clinical trials.
This study looks at blood markers (epigenetics) to better understand why some people have a harder time recovering from a severe infection after major cancer surgery. The goal is to find early signs of poor outcomes in men aged 45–75 with post-surgery sepsis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male
- You are between 45 and 75 years old
- You are having or have had major surgery for cancer of the esophagus or digestive system
- You have a serious infection after surgery (gram-negative bacteria), either confirmed or suspected
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how infections grow and respond to treatment in cancer patients who may have sepsis. It aims to find better ways to diagnose and monitor sepsis early, which could improve care and outcomes.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
This study is testing a blood test that may help doctors diagnose sepsis faster. It involves people with sepsis and healthy volunteers to compare results.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This study looks at how sepsis (a severe infection) affects the immune system. The goal is to see if certain blood markers can help doctors predict recovery, which could improve the care of future patients with septic shock.
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
Hear when a new Sepsis Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.